Image description: cartoon of an individual with a large mustache, a top hat, and cape standing behind a brown and red booth holding test tubes in front of a crowd of stick fingers. The booth has a banner reading "DTC snake oil" at the top and signs that read "Tests 100% of the DNA!", "Test your infant for ALL health conditions!," and "Holiday sale today!" A white speech bubble reads "Step right up! We are the ONLY ones who can give you ALL the answers!"

Direct-to-Consumer is Direct-to-Chaos for Rare Disease Families

Silhouettes of 44 people encircle the text, “Updated 23andMe test still misses moist people with BRCA1/2 hereditary cancer risks”. About 1 in 4 of the people are colored in red and the rest are colored in pink. The pink silhouette is intended to represent people who carry a BRCA1 or BRCA2 pathogenic variant that would be missed by the 23andMe test.
The Value of Knowledge and the Cost of False Reassurance: Understanding the Updates to 23andMe’s BRCA Genetic Testing
cfDNA-term-post-Medium-Banner-US-Landscape
What’s in a (Noninvasive) Name?
Silhouettes of 44 people encircle the text, “Updated 23andMe test still misses moist people with BRCA1/2 hereditary cancer risks”. About 1 in 4 of the people are colored in red and the rest are colored in pink. The pink silhouette is intended to represent people who carry a BRCA1 or BRCA2 pathogenic variant that would be missed by the 23andMe test.
The Value of Knowledge and the Cost of False Reassurance: Understanding the Updates to 23andMe’s BRCA Genetic Testing
cfDNA-term-post-Medium-Banner-US-Landscape
What’s in a (Noninvasive) Name?

satisfying your appetite for genetic news and information

gsf holiday dec newsletter

A note of reflection and gratitude as we close out another year at GSF

Gift image

At-Home Genetic Testing for the Holidays: Think Before You Gift

GSF EXTENDS REACH (1)

GSF Extends Reach Thanks to the Gibbs Family Foundation

A photo of a lightbulb

The Diagnosis Moment

ART 2

Polygenic Embryo Screening: Genetic Counseling Perspectives and Commercial Incentives

Sept 2023 Newsletter Alzheimer Disease (1)

Dementia, Drugs, and DNA

ART 2

Polygenic Embryo Screening: Genetic Counseling Perspectives and Commercial Incentives

Sept 2023 Newsletter Alzheimer Disease (1)

Dementia, Drugs, and DNA

dark mitochondria

Mitochondrial Disease in the News; the darker reality of living with a rare disease

Conta_Jessie 001

Jessie Conta: Laboratory Stewardship Advocate Guides GSF Forward

Balancing act

The Balancing Act of Pre-implantation Genetic Testing for Aneuploidy

Martin

BRCA2 on the TODAY Show: Jill Martin’s Story